CJC-1295 and Ipamorelin come from two different lines of growth-hormone-axis research, which is exactly why they are studied together.
Two research lineages
CJC-1295 descends from work on GHRH (growth-hormone-releasing hormone) analogs — molecules engineered to mimic the natural releasing signal with greater stability. Ipamorelin came from research into selective growth-hormone secretagogues designed to act on a separate receptor pathway with high selectivity.
Why they became a pair
Because one mimics the releasing hormone and the other stimulates release through a complementary route, researchers began studying them together as a blend — see CJC-1295 vs Ipamorelin and their combined mechanism of action.
Product page: CJC-1295 + Ipamorelin research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.